Digital health has been all over the news in recent weeks. There have been announcements from Novo Nordisk and Noom, Abbott and Omada, Astellas and WellDoc, Orexo and GAIA, Ironwood and Pear Therapeutics, and many others. We have heard about Amazon deepening its footprint in healthcare, and Google's collaborations with Stanford Medicine, Cleveland Clinic and Mayo Clinic, as well as numerous other collaboration-based programs through Google's Verily and Google Fit.
In this executive panel, hear from industry leaders about lessons learned from implementing digital health alliances in their organizations:
Brooke Paige, CSAP
Vice President, Alliance Management
Pear Therapeutics (Formerly)
Head of Healthcare Strategic Partnerships
Chris Lento is Head of Healthcare Strategic Partnerships for Noom. Noom is a digital health company focused on behavior change. Chris has 27+ years of healthcare experience and has held roles of increasing scope and responsibility in pharmaceuticals, biotechnology, healthcare technology and digital health. Chris has worked for the past several years helping groups such as: Pear Therapeutics and Palo Alto Health Sciences create and execute commercial go to market strategies. Chris also has a consulting practice helping healthcare organizations to build commercial strategy and launch execution. Chris serves on the Board of Trustees and Programming and Planning Committee for Maine Behavioral Health. He is passionate about improving the availability and quality of healthcare services and technology across the US.
Chris lives in Falmouth Maine with his wife Ann and (3) children Maggie, Collin and Molly. Chris is a passionate outdoorsman and enjoys activities such as skiing, cycling and hiking.
Vice President, Product
Davina thrives on bringing diverse stakeholders together to solve complex problems. With a background in engineering, technical communication, and fine art, she's spent over 20 years empowering teams to find valuable, creative, and engaging solutions.
At Neurotrack, Davina leverages an amazing team, international partnerships, and lean methodologies to transform the diagnosis and prevention of memory loss and related diseases like Alzheimer's. Prior to Neurotrack, she scaled the product platform at Pear Therapeutics, where big pharma alliances are key to developing and marketing the first FDA cleared, prescription digital therapeutics to treat people suffering from a range of serious diseases.
When she's not stoking the fires of cross-functional teams or dreaming up ways technology can improve access to healthcare, Davina can usually be found painting, weaving, or exploring Hyrule in the Legend of Zelda.
Knut Sturmhoefel, CA-AM, PhD
Global Head Novartis Alliance Management